COMMUNIQUÉS West-GlobeNewswire

Adherium Investor Conference Call
06/02/2018
SAN MATEO, Calif., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, will host a conference call on Wednesday, February 7, 2018 at 6: [...]
Shawn Langer Acquires Common Shares of Vaxil Bio Ltd.
06/02/2018
TORONTO, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Shawn Langer announces that on January 26, 2018, he acquired (the " Acquisition ") by way of private placement ownership over 4,985,000 units (" Units ") of Vaxil Bio Ltd. ( [...]
Osiris Appoints Willi Miesch to its Board of Directors, Change in CEO
06/02/2018
COLUMBIA, Md., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (Pink Sheets:OSIR) is pleased to announce that its Board of Directors, at a Board Meeting on February 6 th , 2018, appointed Mr. Willi Miesch as [...]
Pernix Announces Appointment of Lead Independent Director and Key Management Team Promotion
06/02/2018
Director John R. Leone Named as the Company’s Lead Independent Director Angus Smith Promoted to Senior Vice President, Chief Business Officer and Principal Financial Officer MORRISTOWN, N.J., Feb. 06, 2018 (GLOBE [...]
HealthEquity Reports Year-End Sales Metrics
06/02/2018
DRAPER, Utah, Feb. 06, 2018 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY ) ("HealthEquity" or the "Company"), one of the nation's largest health savings account ("HSA") custodians, today announced HSA Member and [...]
Myriad Genetics Reports Fiscal Second-Quarter 2018 Financial Results
06/02/2018
Total Revenues of $194.0 Million GAAP Diluted EPS of $0.45 and Adjusted EPS of $0.31 Up 19 Percent Company Raises Financial Guidance for Fiscal Year 2018 SALT LAKE CITY, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics [...]
Misonix Reports Record Second Quarter Revenue
06/02/2018
FARMINGDALE, N.Y., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON ) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]
TiGenix: Transparency Information
06/02/2018
PRESS RELEASE REGULATED INFORMATION Transparency Information Leuven (BELGIUM) - February 6, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG) publishes information in accordance with articles 15 and 18 [...]
Cerner Reports Fourth Quarter and Full Year 2017 Results
06/02/2018
KANSAS CITY, Mo., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN ) today announced results for the 2017 fourth quarter and full year that ended December 30, 2017. Bookings in the fourth quarter of [...]
Diffusion Pharmaceuticals to Present at the 2018 BIO CEO & Investor Conference
06/02/2018
CHARLOTTESVILLE, Va., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN ) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on extending the life expectancy of [...]
Curetis Unyvero HPN Application Receives Singapore Health Sciences Authority Approval; Updates on Sepsis Host Response Test
06/02/2018
Curetis Unyvero HPN Application Receives Singapore Health Sciences Authority Approval; Updates on Sepsis Host Response Test Market authorization paves way for broader Unyvero commercial roll-out in ASEAN region through [...]
Bavarian Nordic Announces Positive Results of Pivotal Phase 3 Study of IMVAMUNE® Smallpox Vaccine
06/02/2018
Study successfully achieved both primary endpoints Second positive Phase 3 demonstrating the safety and efficacy of IMVAMUNE and final study required for licensure, as agreed with FDA BLA filing expected in second half [...]
It’s Time to Build an “Own the Podium” Program for Home Care in Canada, Says VHA Home HealthCare CEO Carol Annett
06/02/2018
TORONTO, Feb. 06, 2018 (GLOBE NEWSWIRE) -- VHA Home HealthCare: Expectations are high for Canada’s medal performance at this month’s Winter Olympics in PyeongChang. After our impressive showing in Rio, which surpassed [...]
Lumere Names John Cherf, MD, MPH, MBA, as Its First-Ever Chief Medical Officer
06/02/2018
CHICAGO, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Lumere, the leading provider of data-driven analytics, evidence and expert guidance to help health systems reduce unnecessary clinical variation and costs, today announced the [...]
Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2018
06/02/2018
Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2018 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
Essilor : Nombre total de droits de vote et d'actions composant le capital social au 31 janvier 2018
06/02/2018
Nombre total de droits de vote et d'actions composant le capital social au 31 janvier 2018 (Article L.233-8 II du Code de Commerce et les articles 221-1 et 223-16 du Règlement Général de l'AMF) Charenton-le-Pont, France [...]
VALNEVA : Déclaration d'actions et de droits de vote - Janvier 2018
06/02/2018
VALNEVA Déclaration d'actions et de droits de vote - JANVIER 2018 Dénomination sociale : VALNEVA Adresse du siège social : World Trade Center Lyon - Tour Oxygène, 10-12 Boulevard Marius Vivier Merle, 69003 Lyon Marché [...]
Poster presentation at WORLDSymposium™ 2018 – arimoclomol as clinical candidate for treatment of Gaucher disease
06/02/2018
Investor news Orphazyme A/S No. 02/2018 Copenhagen, February 6, 2018 – Orphazyme A/S , a Danish biotech company listed on Nasdaq Copenhagen (TICKER: ORPHA.CO), with a late-stage, orphan-drug pipeline, today announced [...]
GW Pharmaceuticals to Present at the Leerink Partners 7th Annual Global Healthcare Conference on 14 February
06/02/2018
LONDON and CARLSBAD, Calif., Feb. 06, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH ) (GW, the Company or the Group), a biopharmaceutical company focused on discovering, developing and commercializing [...]

Pages